The deacylation mechanism of AmpC β-lactamase at ultrahigh resolution

被引:74
作者
Chen, Y
Minasov, G
Roth, TA
Prati, F
Shoichet, BK
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
[2] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA
[3] Univ Modena, Dipartimento Chim, I-183 Modena, Italy
关键词
D O I
10.1021/ja056806m
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
beta-Lactamases confer bacterial resistance to beta-lactam antibiotics, such as penicillins. The characteristic class C beta-lactamase AmpC catalyzes the reaction with several key residues including Ser64, Tyr150, and Lys67. Here, we describe a 1.07 angstrom X-ray crystallographic structure of AmpC beta-lactamase in complex with a boronic acid deacylation transition-state analogue. The high quality of the electron density map allows the determination of many proton positions. The proton on the Tyr150 hydroxyl group is clearly visible and is donated to the boronic oxygen mimicking the deacylation water. Meanwhile, Lys67 hydrogen bonds with Ser640 gamma, Asn152O delta 1, and the backbone oxygen of Ala220. This suggests that this residue is positively charged and has relinquished the hydrogen bond with Tyr150 observed in acyl-enzyme complex structures. Together with previous biochemical and NMR studies, these observations indicate that Tyr150 is protonated throughout the reaction coordinate, disfavoring mechanisms that involve a stable tyrosinate as the general base for deacylation. Rather, the hydroxyl of Tyr150 appears to be well positioned to electrostatically stabilize the negative charge buildup in the tetrahedral high-energy intermediate. This structure, in itself, appears consistent with a mechanism involving either Tyr150 acting as a transient catalytic base in conjunction with a neutral Lys67 or the lactam nitrogen as the general base. Whereas mutagenesis studies suggest that Lys67 may be replaced by an arginine, disfavoring the conjugate base mechanism, distinguishing between these two hypotheses may ultimately depend on direct determination of the pK(a) of Lys67 along the reaction coordinate.
引用
收藏
页码:2970 / 2976
页数:7
相关论文
共 41 条
[31]   Crystal structures of substrate and inhibitor complexes with AmpC β-lactamase:: Possible implications for substrate-assisted catalysis [J].
Patera, A ;
Blaszczak, LC ;
Shoichet, BK .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (43) :10504-10512
[32]   Structure-based approach for binding site identification on AmpC β-lactamase [J].
Powers, RA ;
Shoichet, BK .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (15) :3222-3234
[33]   Structures of ceftazidime and its transition-state analogue in complex with AmpC β-lactamase:: Implications for resistance mutations and inhibitor design [J].
Powers, RA ;
Caselli, E ;
Focia, PJ ;
Prati, F ;
Shoichet, BK .
BIOCHEMISTRY, 2001, 40 (31) :9207-9214
[34]   THE CHEMICAL-REACTIVITY OF PENICILLINS AND OTHER BETA-LACTAM ANTIBIOTICS [J].
PROCTOR, P ;
GENSMANTEL, NP ;
PAGE, MI .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1982, (09) :1185-1192
[35]   Thermodynamic cycle analysis and inhibitor design against beta-lactamase [J].
Roth, TA ;
Minasov, G ;
Morandi, S ;
Prati, F ;
Shoichet, BK .
BIOCHEMISTRY, 2003, 42 (49) :14483-14491
[36]   SHELXL: High-resolution refinement [J].
Sheldrick, GM ;
Schneider, TR .
MACROMOLECULAR CRYSTALLOGRAPHY, PT B, 1997, 277 :319-343
[37]   Structure-function studies of Ser-289 in the class C β-lactamase from Enterobacter cloacae P99 [J].
Trépanier, S ;
Knox, JR ;
Clairoux, N ;
Sanschagrin, F ;
Levesque, RC ;
Huletsky, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (03) :543-548
[38]   ROLE OF LYSINE-67 IN THE ACTIVE-SITE OF CLASS-C BETA-LACTAMASE FROM CITROBACTER-FREUNDII GN346 [J].
TSUKAMOTO, K ;
TACHIBANA, K ;
YAMAZAKI, N ;
ISHII, Y ;
UJIIE, K ;
NISHIDA, N ;
SAWAI, T .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 188 (01) :15-22
[39]   Mutational replacement of Leu-293 in the class C Enterobacter cloacae P99 β-lactamase confers increased MIC of cefepime [J].
Vakulenko, SB ;
Golemi, D ;
Geryk, B ;
Suvorov, M ;
Knox, JR ;
Mobashery, S ;
Lerner, SA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) :1966-1970
[40]   THE IMPORTANCE OF THE NEGATIVE CHARGE OF BETA-LACTAM COMPOUNDS IN THE INTERACTIONS WITH ACTIVE-SITE SERINE DD-PEPTIDASES AND BETA-LACTAMASES [J].
VARETTO, L ;
DEMEESTER, F ;
MONNAIE, D ;
MARCHANDBRYNAERT, J ;
DIVE, G ;
JACOB, F ;
FRERE, JM .
BIOCHEMICAL JOURNAL, 1991, 278 :801-807